← Leaderboards
Nicole Cherie Schmitt
University Of Washington
$1,134,295
Attributed
$1,699,021
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $688K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,699,021 · 4
By mechanism
U01$1,129,452 · 1
K24$288,656 · 1
R21$234,750 · 1
F32$46,163 · 1
Top collaborators
- Nabil F Saba2 shared
Most similar at University Of Washington
Same institution · by research overlap
- Edwin W Rubel$15,520,530
- David W Raible$21,473,931
- Lisa L Cunningham$2,377,881
- Noah S Seixas$5,763,283
- Patrick S. Stayton$27,743,768
Others in their field
Top investigators on “Cisplatin”
- Philip J Disaia · University Of California Irvine$57,355,877
- Robert C Park · American College Of Ob And Gyn$16,339,593
- Aziz Sancar · University Of North Carolina Chapel Hill$11,887,517
- Manijeh N Goldberg · Privo Technologies, Llc$11,254,955
- Lois B. Travis · University Of Rochester$11,212,396
- Stephen J Lippard · Boston University Medical Campus$9,887,688
Research focus
CisplatinHearing ImpairmentOtotoxicityHead And Neck CancerRadiationChemotherapyRandomizedScheduleHearing TestsPublishingIncidenceChemotherapy And/Or RadiationAftercareChemoradiationQuality Of LifeExtramural ActivitiesDesignHyperlipidemiaCancer SurvivorHead And Neck Cancer PatientCancer TherapyCommunicationAtorvastatinSite
Grant awards (6)
Systemic/Abscopal Anti-Tumor Immune Responses during IAP Antagonism and Radiation$234,750
R21 · FY2025 · DE · contact PI
Patient Oriented Research in Communication and Swallowing Disorders$144,328
K24 · FY2025 · DC · contact PI
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss in Head and Neck Cancer Patients$543,623
U01 · FY2024 · DC · contact PI
Patient Oriented Research in Communication and Swallowing Disorders$144,328
K24 · FY2024 · DC · contact PI
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss in Head and Neck Cancer Patients$585,829
U01 · FY2023 · DC · contact PI
The Role of STAT1 in Cisplatin-Induced Hair Cell Death$46,163
F32 · FY2008 · DC · contact PI